
Frontiers in Pharmacology, Год журнала: 2020, Номер 11
Опубликована: Март 13, 2020
REVIEW article Front. Pharmacol., 13 March 2020Sec. Neuropharmacology Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.00279
Язык: Английский
Frontiers in Pharmacology, Год журнала: 2020, Номер 11
Опубликована: Март 13, 2020
REVIEW article Front. Pharmacol., 13 March 2020Sec. Neuropharmacology Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.00279
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2020, Номер 163, С. 1599 - 1617
Опубликована: Авг. 9, 2020
Язык: Английский
Процитировано
184Molecular Neurodegeneration, Год журнала: 2020, Номер 15(1)
Опубликована: Ноя. 4, 2020
Abstract Investigations of apolipoprotein E ( APOE ) gene, the major genetic risk modifier for Alzheimer’s disease (AD), have yielded significant insights into pathogenic mechanism. Among three common coding variants, APOE*ε4 increases, whereas APOE*ε2 decreases late-onset AD compared with APOE*ε3 . Despite increased understanding detrimental effect , it remains unclear how confers protection against AD. Accumulating evidence suggests that protects through both amyloid-β (Aβ)-dependent and independent mechanisms. In addition, has been identified as a longevity suggesting systemic on aging process. However, is not entirely benign; carriers exhibit certain cerebrovascular diseases neurological disorders. Here, we review from human animal studies demonstrating protective propose working model depicting potential underlying Finally, discuss therapeutic strategies designed to leverage APOE2 treat
Язык: Английский
Процитировано
184Ageing Research Reviews, Год журнала: 2021, Номер 68, С. 101339 - 101339
Опубликована: Апрель 5, 2021
Язык: Английский
Процитировано
177Ageing Research Reviews, Год журнала: 2020, Номер 64, С. 101045 - 101045
Опубликована: Март 19, 2020
As the population ages, number of people with dementia is expected to increase in coming decades, consequences at societal and individual levels. In this narrative review, we provide a summary scientific evidence concerning prevention, focus on following three strategies: 1) Targeting body protect brain, including prevention treatment cardiovascular morbidity; 2) Compensatory interventions counteract brain ageing, education life-long engagement cognitively socially stimulating activities; 3) Lifespan health promotion, such as physically active lifestyle, smoking cessation, healthy balanced diet. Next, consider biological mechanisms by which these strategies may act taking into account main pathways implicated development progression dementia: neurodegeneration, resilience, vascular damage, neuroinflammation, oxidative stress. Based current evidence, line declining trends incidence high-income countries, conclude that timely multidomain preventive actions are promising reduce epidemic worldwide. There still considerable gap between epidemiological its underlying mechanisms. Filling will be crucial move forward
Язык: Английский
Процитировано
176Frontiers in Pharmacology, Год журнала: 2020, Номер 11
Опубликована: Март 13, 2020
REVIEW article Front. Pharmacol., 13 March 2020Sec. Neuropharmacology Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.00279
Язык: Английский
Процитировано
169